Evaluation of serum level of omentin-1 in females with hirsutism

被引:6
|
作者
Kenawi, Mohammed Z. [1 ]
Akl, Essam M. [1 ]
Sabry, Jehan H. [2 ]
Mostafa, Sara T. [3 ]
机构
[1] Benha Univ, Fac Med, Dept Dermatol Venereol & Androl, PO 13511, Banha, Egypt
[2] Benha Univ, Dept Clin Pathol, Fac Med, Banha, Egypt
[3] Benha Univ, Fac Med, Dept Obstet & Gynecol, Banha, Egypt
关键词
hirsutism; omentin-1; polycystic ovary syndrome; testosterone; HAIR; MANAGEMENT; PROLIFERATION; DIAGNOSIS; CONSENSUS;
D O I
10.1111/jocd.13043
中图分类号
R75 [皮肤病学与性病学];
学科分类号
100206 ;
摘要
Background Hirsutism is a common clinical condition encountered in day-to-day practice. The androgenic causes account for more than 80% of these patients and include polycystic ovary syndrome (PCOS), which affects about 70%-80% of hirsute women. The second most common cause is idiopathic hirsutism. Omentin-1 is an adipokine mainly produced by visceral adipose tissue. Aim The current study aimed at evaluating omentin-1 levels in hirsute females with PCOS and in idiopathic hirsutism. Patients and Methods Eighty-five females were included in this study. They were classified into three groups: thirty hirsute patients with PCOS, thirty females with idiopathic hirsutism, and twenty-five healthy control females. The participants were subjected to history taking, physical and dermatological examination. A gynecological history and radiological examination of the ovary also were done. Serum testosterone and omentin-1 were measured by ELISA. Results Serum testosterone was statistically elevated in PCOS than other groups. Serum omentin-1 in females with idiopathic hirsutism was statistically significantly higher than control and PCOS. There was a significant inverse correlation between serum testosterone level and serum omentin-1 level. Conclusion Omentin-1 may be involved in the pathogenic process of hirsutism.
引用
收藏
页码:535 / 539
页数:5
相关论文
共 50 条
  • [1] Serum Omentin-1 in Psoriasis
    Bakry, Ola Ahmed
    El Farargy, Shawky
    Ghanayem, Naglaa
    Galal, Somia
    INDIAN JOURNAL OF DERMATOLOGY, 2018, 63 (01) : 85 - +
  • [2] Serum omentin-1 level in patients with benign prostatic hyperplasia
    He, Haiqing
    Wu, Shuiqing
    Hao, Jun
    Wang, Long
    Ai, Kai
    Zhu, Xuan
    Xu, Ran
    Zhao, Xiaokun
    Wang, Yinhuai
    Zhong, Zhaohui
    BMC UROLOGY, 2020, 20 (01)
  • [3] Serum omentin-1 level in patients with benign prostatic hyperplasia
    Haiqing He
    Shuiqing Wu
    Jun Hao
    Long Wang
    Kai Ai
    Xuan Zhu
    Ran Xu
    Xiaokun Zhao
    Yinhuai Wang
    Zhaohui Zhong
    BMC Urology, 20
  • [4] Serum omentin-1 levels in obese children
    Zengi, Senay
    Zengi, Oguzhan
    Kirankaya, Aysegul
    Kucuk, Suat Hayri
    Kutanis, Emine Erdogan
    Yigit, Ozgul
    JOURNAL OF PEDIATRIC ENDOCRINOLOGY & METABOLISM, 2019, 32 (03): : 247 - 251
  • [5] Evaluation of serum omentin-1 and apelin concentrations in patients with hidradenitis suppurativa
    Gonzalez-Lopez, Marcos A.
    Ocejo-Vinals, J. Gonzalo
    Mata, Cristina
    Diaz, Diego
    Guiral, Sandra
    Portilla, Virginia
    Corrales, Alfonso
    Gonzalez-Vela, M. Carmen
    Gonzalez-Gay, Miguel A.
    Blanco, Ricardo
    Hernandez, Jose L.
    POSTEPY DERMATOLOGII I ALERGOLOGII, 2021, 38 (03): : 450 - 454
  • [6] SERUM OMENTIN-1 LEVEL IS ASSOCIATED WITH THE AGGREGATION OF CARDIOVASCULAR RISK FACTORS IN ADOLESCENTS
    Chen, Y.
    Zhang, J.
    Li, L.
    Liu, C.
    Li, P.
    ACTA ENDOCRINOLOGICA-BUCHAREST, 2023, 19 (01) : 19 - 24
  • [7] Serum omentin-1 levels in hypertensive patients
    Celik, Mustafa
    Nar, Rukiye
    Nar, Gokay
    Sokmen, Erdogan
    Gunver, Guven
    JOURNAL OF HUMAN HYPERTENSION, 2021, 35 (03) : 290 - 295
  • [8] Serum omentin-1 levels in hypertensive patients
    Mustafa Çelik
    Rukiye Nar
    Gökay Nar
    Erdoğan Sökmen
    Güven Günver
    Journal of Human Hypertension, 2021, 35 : 290 - 295
  • [9] SERUM OMENTIN-1 LEVELS AND ENDOTHELIAL DYSFUNCTION IN OBESITY
    Cimen, A. R.
    Cerit, E. T.
    Iyidiri, O. T.
    Karakus, R.
    Uyar, B. B.
    Toruner, F. B.
    Cakir, N.
    Arslan, M.
    ACTA ENDOCRINOLOGICA-BUCHAREST, 2017, 13 (02) : 138 - 143
  • [10] Effect of Ibandronate Therapy on Serum Chemerin, Vaspin, Omentin-1 and Osteoprotegerin (OPG) in Postmenopausal Osteoporotic Females
    Tariq, Saba
    Tariq, Sundus
    Abualhamael, Shahad Abduljalil
    Shahzad, Muhammad
    FRONTIERS IN PHARMACOLOGY, 2022, 13